In a groundbreaking move to strengthen Nigeria’s healthcare system, GS1 Nigeria has announced its support for the newly gazetted NAFDAC Traceability Regulation. This landmark regulation highlights Nigeria’s commitment to safeguarding the quality, safety, and authenticity of medical products across the country’s supply chain.
The regulation requires stakeholders in the healthcare and pharmaceutical industries to implement traceability practices aimed at enhancing transparency and combating counterfeiting. By adopting GS1 global standards, such as barcoding and serialization, organizations can efficiently comply with the regulation, ensuring the protection of patients and consumers nationwide.
This significant step is expected to bolster trust in the pharmaceutical supply chain, reduce risks associated with counterfeit drugs, and improve public health outcomes.
For more information and to access the official NAFDAC Traceability Regulation document, click below: